Journal Home > Volume 2 , Issue 3
Objective:

Primary intracranial malignant fibrous histiocytoma (MFH) is rare. We describe the detailed clinical features of 8 cases and fully review the literature to evaluate several prognostic factors.

Methods:

Eight patients with pathologically confirmed primary intracranial MFH were retrospectively reviewed. We searched PubMed for relevant articles with the term "intracranial malignant fibrous histiocytoma" .

Results:

Of the 8 patients, 4 were men and 4 were women. Three patients had received previous radiotherapy. The age of the patients ranged from 19 to 69 years, with a median age of 48 years. Most tumors could be totally resected; and only 1 tumor was subtotally resected. Six patients received postoperative radiotherapy and 3 patients received postoperative chemotherapy. Most patients died within the first year after surgery; and only 1 patient was still alive on the date of the last follow-up. We reviewed the literature and included a total of 46 patients in the Kaplan-Meier survival analysis. Young patients (less than 30 years old) seemed to have a better prognosis and survival rate than older patients (more than 30 years old) (log-rank test, P = 0.008). However, sex (P = 0.675), extent of resection (P = 0.934), postoperative radiotherapy (P = 0.592), and postoperative chemotherapy (P = 0.424) did not affect patient prognosis.

Conclusions:

The prognosis of MFH is usually poor, and most patients die within the first year after surgery. Younger MFH patients (less than 30 years old) seem to have a better prognosis and improved survival compared to older patients.


menu
Abstract
Full text
Outline
About this article

Clinical features and prognostic factors of primary intracranial malignant fibrous histiocytoma: A report of 8 cases and a literature review

Show Author's information Peng Li1Qiangyi Zhou1Zhijun Yang1Zhenmin Wang1Shiwei Li1Xingchao Wang1Bo Wang1Fu Zhao2Pinan Liu1,2( )
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China
Department of Neural Reconstruction, Beijing Neurosurgery Institute, Capital Medical University, Beijing 100050, China

Abstract

Objective:

Primary intracranial malignant fibrous histiocytoma (MFH) is rare. We describe the detailed clinical features of 8 cases and fully review the literature to evaluate several prognostic factors.

Methods:

Eight patients with pathologically confirmed primary intracranial MFH were retrospectively reviewed. We searched PubMed for relevant articles with the term "intracranial malignant fibrous histiocytoma" .

Results:

Of the 8 patients, 4 were men and 4 were women. Three patients had received previous radiotherapy. The age of the patients ranged from 19 to 69 years, with a median age of 48 years. Most tumors could be totally resected; and only 1 tumor was subtotally resected. Six patients received postoperative radiotherapy and 3 patients received postoperative chemotherapy. Most patients died within the first year after surgery; and only 1 patient was still alive on the date of the last follow-up. We reviewed the literature and included a total of 46 patients in the Kaplan-Meier survival analysis. Young patients (less than 30 years old) seemed to have a better prognosis and survival rate than older patients (more than 30 years old) (log-rank test, P = 0.008). However, sex (P = 0.675), extent of resection (P = 0.934), postoperative radiotherapy (P = 0.592), and postoperative chemotherapy (P = 0.424) did not affect patient prognosis.

Conclusions:

The prognosis of MFH is usually poor, and most patients die within the first year after surgery. Younger MFH patients (less than 30 years old) seem to have a better prognosis and improved survival compared to older patients.

Keywords: literature review, clinical features, prognostic factors, intracranial malignant fibrous histiocytoma

References(42)

[1]
Pimentel J, Fernandes A, Távora L, Miguéns J, Lobo Antunes J. Benign isolated fibrohistiocytic tumor arising from the central nervous system. Considerations about two cases. Clin Neuropathol 2002, 21(3): 93–98.
[2]
Deb P, Singh V, Dutta V, Bhatoe HS, Chandran VM. Primary intracranial benign fibrous histiocytoma: Report of an unusual case. J Cancer Res Ther 2014, 10(1): 200–202.
[3]
Moliterno JA, Sood S, Zambrano E, Kim JH, Piepmeier JM, Baehring JM. Intracranial benign fibrous histiocytomas: A case report and review. J Neurooncol 2009, 92(2): 203–209.
[4]
Hayami J, Kurokawa I, Hashimoto K, Kusumoto K. Malignant fibrous histiocytoma of scalp with intracranial invasion 20 years after postoperative irradiation. J Craniofac Surg 2003, 14(1): 74–77.
[5]
Hamlat A, Adn M, Caulet-Maugendre S, Guegan Y. Cerebellar malignant fibrous histiocytoma: Case report and literature review. Neurosurgery 2004, 54(3): 745–751.
[6]
Gelabert-González M, Fernández-Villa JM, Reyes-Santías R. Histiocitoma fibroso maligno de duramadre. Neurocirugía 2003, 14(3): 235–239.
[7]
Broniscer A, Ke W, Fuller CE, Wu J, Gajjar A, Kun LE. Second neoplasms in pediatric patients with primary central nervous system tumors: The St. Jude Children’s Research Hospital experience. Cancer 2004, 100(10): 2246–2252.
[8]
Mitsuhashi T, Watanabe M, Ohara Y, Hatashita S, Ueno H. Multifocal primary intracerebral malignant fibrous histiocytoma—Case report. Neurol Med Chir (Tokyo) 2004, 44(5): 249–254.
[9]
Maruno M, Ghulam Muhammad AKM, Taguchi J, Suzuki T, Wada K, Isaka T, Yoshimine T. Giant cell type of primary intracranial malignant fibrous histiocytoma: A case report. Brain Tumor Pathol 2006, 23(1): 65–70.
[10]
Harries AM, Mitchell R. Haemorrhagic cerebellar fibrous histiocytoma: Case report and literature review. Br J Neurosurg 2011, 25(1): 120–121.
[11]
Sarrami AH, Setareh M, Afshar-Moghaddam N, Izadinejad M, Saadatnia M. A case of intracranial malignant fibrous histiocytoma. J Res Med Sci 2011, 16(7): 968–973.
[12]
Gelincik I. Cerebellar malignant fibrous histiocytoma. Indian J Pathol Microbiol 2012, 55(3): 402–405.
[13]
Ozdemir M, Ozgural O, Bozkurt M, Torun FM, Heper AO, Tuna H. Primary intracerebral malignant fibrous histiocytoma mimicking a meningioma. Turk Neurosurg 2012, 22(4): 475–477.
[14]
Grahovac G, Chudy D, Heinrich Z, Zarkovic K. Implantation metastasis of malignant fibrous histiocytoma along the stereotactic biopsy tract. Clin Neurol Neurosurg 2013, 115(7): 1160–1161.
[15]
Yoo RE, Choi SH, Park SH, Jung HW, Kim JH, Sohn CH, Chang KH. Primary intracerebral malignant fibrous histiocytoma: CT, MRI, and PET-CT findings. J Neuroimaging 2013, 23(1): 141–144.
[16]
Kurosaki M, Kambe A, Ishibashi M, Watanabe T, Horie Y. A case report of sarcoma of the sella caused by postoperative radiotherapy for a prolactin-producing pituitary adenoma. Brain Tumor Pathol 2014, 31(3): 187–191.
[17]
Özhan S, Tali ET, Işik S, Saygili MR, Baykaner K. Haematoma-like primary intracranial malignant fibrous histiocytoma in a 5-year-old girl. Neuroradiology 1999, 41(7): 523–525.
[18]
Fritz MA, Sade B, Bauer TW, Wood BG, Lee JH. Benign fibrous histiocytoma of the pterygopalatine fossa with intracranial extension. Acta Neurochir 2006, 148(1): 73–76.
[19]
Graber JJ, Nayar A, Zagzag D. Metastatic cerebral malignant fibrous histiocytoma masquerading as neurocysticercosis. J Neurooncol 2011, 105(2): 437439.10.1007/s11060-011-0583-8
[20]
Schrader B, Holland BR, Friedrichsen C. Rare case of a primary malignant fibrous histiocytoma of the brain. Neuroradiology 1989, 31(2): 177–179.
[21]
Mahore A, Ramdasi R, Dange N, Epari S. Malignant fibrous histiocytoma of the skull base: A neurosurgical nuance. Asian J Neurosurg 2015, 10(2): 135–138.
[22]
Wang J, Zhong WM, Xu YH, Feng L, Li Y, Dong B. A primary malignant fibrous histiocytoma of the scalp and intracranial tumor bleeding: A case report. J Med Case Rep 2014, 8: 50.
[23]
Matsuura S, Takagi T, Tan EC, Mizuno S, Imagunbai N, Hasegawa R. Malignant fibrous histiocytoma of the occipital bone with intracranial extension—Case report. Neurol Med Chir (Tokyo) 1991, 31(4): 219–222.
[24]
Wu TH, Shih CW, Huang JS, Wang CH, Yeh KY. Unusual hematogenous brain metastasis in malignant fibrous histiocytoma of the maxillary sinus. Int J Clin Oncol 2012, 17(1): 69–74.
[25]
Itoyama Y, Nagahiro S, Seto H, Sueyoshi N, Kuratsu JI, Ushio Y. Brain metastasis from malignant fibrous histiocytoma of the heart: Case report. Neurosurgery 1990, 26(4): 692–695.
[26]
Gonzalez-Vitale JC, Slavin RE, McQueen JD. Radiation-induced intracranial malignant fibrous histiocytoma. Cancer 1976, 37(6): 2960–2963.
DOI
[27]
Baehring JM, Alemohammed S, Croul SE. Malignant fibrous histiocytoma presenting as an intraventricular mass five years after incidental detection of a mass lesion. J Neurooncol 2001, 52(2): 157–160.
[28]
Hirato J, Nakazato Y, Sasaki A, Yokota M, Nojiri K, Toyoda O, Nakajima H. Intracranial malignant fibrous histiocytoma: Characterization of GFAP-positive cells in the tumor. Clin Neuropathol 1994, 13(6): 315–322.
[29]
Amendola BE, Amendola MA, McClatchey KD. Radiation-induced malignant fibrous histiocytoma: A report of five cases including two occurring post whole brain irradiation. Cancer Invest 1985, 3(6): 507–513.
[30]
Martinez-Salazar A, Supler M, Rojiani AM. Primary intracerebral malignant fibrous histiocytoma: Immunohistochemical findings and etiopathogenetic considerations. Mod Pathol 1997, 10(2): 149–154.
[31]
Paulus W, Peiffer J, Grote E. Intracerebral malignant fibrous histiocytoma at site of a previously excised low grade glioma. Acta Neurochir (Wien) 1989, 99(3–4): 161–165.
[32]
Bora H, Oztürk B, Akmansu M, Yenidunya S, Egehan I. Intracerebral malignant fibrous histiocytoma in a 5-year-old girl. Radiat Med 1999, 17(5): 355–358.
[33]
Kalyanaraman UP, Taraska JJ, Fierer JA, Elwood PW. Malignant fibrous histiocytoma of the meninges. Histological, ultrastructural, and immunocytochemical studies. J Neurosurg 1981, 55(6): 957–962.
[34]
Akimoto J, Takeda Y, Hasue M, Ito H, Kiguchi E. Primary meningeal malignant fibrous histiocytoma with cerebrospinal dissemination and pulmonary metastasis. Acta Neurochir (Wien) 1998, 140(11): 1191–1196.
[35]
Ho YS, Wei CH, Tsai MD, Wai YY. Intracerebral malignant fibrous histiocytoma: Case report and review of the literature. Neurosurgery 1992, 31(3): 567–570.
[36]
Berry AD 3rd, Reintjes SL, Kepes JJ. Intracranial malignant fibrous histiocytoma with abscess-like tumor necrosis. Case report. J Neurosurg 1988, 69(5): 780–784.
[37]
Kepes JJ. “Xanthomathous” lesions of the central nervous system: Definition, classification and some recent observations. In Progress in Neuropathology Vol. 4. Zimmerman HMN, Ed. New York: Raven, 1979, pp 179–213.
[38]
Akai T, Yamamoto K, Iida T, Iizuka H, Nojima T. Malignant fibrous histiocytoma in the craniocervical junction presenting with severe occipitalgia. Brain Tumor Pathol 2006, 23(2): 101–105.
[39]
Le Doussal V, Coindre JM, Leroux A, Hacene K, Terrier P, Bui NB, Bonichon F, Collin F, Mandard AM, Contesso G. Prognostic factors for patients with localized primary malignant fibrous histiocytoma: A multicenter study of 216 patients with multivariate analysis. Cancer 1996, 77(9): 1823–1830.
DOI
[40]
Fujimura N, Sugita Y, Hirohata M, Naohisa M, Terasaki M, Tokutmi T, Shigemori M. Primary intracerebral malignant fibrous histiocytoma in a child. Pediatr Neurosurg 2002, 37(5): 271–274.
[41]
Pople IK, Harding B. Primary intracranial malignant fibrous histiocytoma in a 5-year-old boy: Case report. Br J Neurosurg 1991, 5(5): 509–513.
[42]
Chhabra R, Gupta SK, Manjunath Prasad KS, Gupta D, Vasishta RK, Sharma RK, Khosla VK. Calvarial malignant fibrous histiocytoma. Neurol India 2004, 52(3): 387–390.
Publication history
Copyright
Rights and permissions

Publication history

Received: 10 July 2016
Revised: 10 July 2016
Accepted: 20 August 2016
Published: 01 September 2016
Issue date: September 2016

Copyright

© The authors 2016.

Rights and permissions

This article is published with open access at www.TNCjournal.com

Return